Rmb Capital Management, LLC Vertex Pharmaceuticals Inc Transaction History

Rmb Capital Management, LLC

  • $4.3 Billion
  • Q3 2024

A detailed history of Rmb Capital Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Rmb Capital Management, LLC holds 1,580 shares of VRTX stock, worth $711,584. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,580
Previous 1,509 4.71%
Holding current value
$711,584
Previous $707,000 3.82%
% of portfolio
0.02%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
BUY
$460.0 - $505.78 $32,660 - $35,910
71 Added 4.71%
1,580 $734,000
Q2 2024

Aug 13, 2024
BUY
$392.81 - $485.53 $125,306 - $154,884
319 Added 26.81%
1,509 $707,000
Q1 2024

May 14, 2024
BUY
$407.69 - $446.08 $4,484 - $4,906
11 Added 0.93%
1,190 $497,000
Q4 2023

Feb 14, 2024
BUY
$343.0 - $410.68 $19,208 - $22,998
56 Added 4.99%
1,179 $479,000
Q3 2023

Nov 13, 2023
BUY
$338.18 - $362.46 $39,567 - $42,407
117 Added 11.63%
1,123 $390,000
Q2 2023

Aug 11, 2023
BUY
$314.42 - $351.91 $3,458 - $3,871
11 Added 1.11%
1,006 $354,000
Q4 2022

Feb 14, 2023
BUY
$285.76 - $321.48 $284,331 - $319,872
995 New
995 $287,000
Q4 2020

Feb 11, 2021
SELL
$207.01 - $276.09 $241,580 - $322,197
-1,167 Closed
0 $0
Q3 2020

Nov 10, 2020
SELL
$255.65 - $303.1 $54,197 - $64,257
-212 Reduced 15.37%
1,167 $318,000
Q2 2020

Aug 05, 2020
BUY
$225.48 - $295.8 $310,936 - $407,908
1,379 New
1,379 $400,000
Q1 2020

May 11, 2020
SELL
$199.77 - $247.81 $1.6 Million - $1.98 Million
-7,994 Reduced 86.92%
1,203 $286,000
Q4 2019

Feb 13, 2020
SELL
$166.71 - $223.91 $1.26 Million - $1.7 Million
-7,587 Closed
0 $0
Q3 2019

Nov 12, 2019
SELL
$166.23 - $187.09 $1.11 Million - $1.25 Million
-6,685 Reduced 46.84%
7,587 $1.29 Million
Q2 2019

Aug 13, 2019
SELL
$164.61 - $190.37 $136,790 - $158,197
-831 Reduced 5.5%
14,272 $2.62 Million
Q1 2019

May 15, 2019
SELL
$163.73 - $194.7 $984,017 - $1.17 Million
-6,010 Reduced 28.47%
15,103 $2.78 Million
Q4 2018

Feb 13, 2019
BUY
$151.91 - $192.21 $93,728 - $118,593
617 Added 3.01%
21,113 $3.5 Million
Q3 2018

Nov 14, 2018
BUY
$167.73 - $192.74 $844,017 - $969,867
5,032 Added 32.54%
20,496 $3.95 Million
Q2 2018

Aug 13, 2018
SELL
$145.72 - $169.96 $919,201 - $1.07 Million
-6,308 Reduced 28.97%
15,464 $0
Q1 2018

May 14, 2018
BUY
$151.6 - $177.13 $3.3 Million - $3.86 Million
21,772 New
21,772 $3.55 Million

Others Institutions Holding VRTX

# of Institutions
1,723
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Rmb Capital Management, LLC Portfolio

Follow Rmb Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rmb Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rmb Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email